TBH Global Asset Management’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Hold
60,322
0.08% 194
2025
Q4
$329K Hold
60,322
0.05% 203
2025
Q3
$373K Hold
60,322
0.07% 197
2025
Q2
$378K Hold
60,322
0.08% 142
2025
Q1
$353K Hold
60,322
0.07% 149
2024
Q4
$496K Hold
60,322
0.12% 145
2024
Q3
$537K Hold
60,322
0.12% 149
2024
Q2
$456K Hold
60,322
0.1% 160
2024
Q1
$474K Hold
60,322
0.09% 162
2023
Q4
$534K Buy
60,322
+27,225
+82% +$231K 0.11% 139
2023
Q3
$297K Hold
33,097
0.06% 209
2023
Q2
$409K Hold
33,097
0.08% 168
2023
Q1
$307K Buy
+33,097
New +$344K 0.07% 179

Other funds holding AURA

TBH Global Asset Management's AURA Position: Q1 2026 in Review

TBH Global Asset Management held its Aura Biosciences (AURA) position steady in Q1 2026 at 60,322 shares worth $404K. The position accounts for 0.08% of the portfolio, ranked #194.

TBH Global Asset Management first reported a position in AURA in Q1 2023 and has held it in 13 quarters since. The position peaked at $537K in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • TBH Global Asset Management held 60,322 shares of Aura Biosciences worth $404K as of Q1 2026.
  • TBH Global Asset Management left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up 0.08% of TBH Global Asset Management's portfolio in Q1 2026, its #194 holding.
  • TBH Global Asset Management first reported a position in Aura Biosciences in Q1 2023 and has held it in 13 quarters since.
  • TBH Global Asset Management's Aura Biosciences position peaked at $537K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on TBH Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.